 New York, New York--Newsfile Corp. - February 9, 2021 - PCG Digital - Chris Bunka is a happy man. As CEO of Lexaria Bioscience NASDAQ: LEXX since 2006, hes battled to legitimize cannabinoids as a mainstream medical solution. This week, his dream is coming true. Jazz Pharmaceuticals, a major player with 2.3 billion in annual revenue, has entered the fray.The deal went down on Wednesday, February 3rd. Jazz completed an acquisition of GW Pharmaceuticals,... 